Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| CG Oncology, Inc.(CGON) | 6,371,669 | 6,371,669 | 0 | $182.74M | $156.04M | 43.77% | -$26.70M |
| Nuvation Bio Inc.(NUVB) | 25,954,439 | 25,954,439 | 0 | $69.04M | $45.68M | 12.81% | -$23.36M |
| Aardvark Therapeutics Inc | 0 | 3,917,299 | +3,917,299 | $0 | $29.42M | 8.25% | +$29.42M |
| Upstream Bio, Inc.(UPB) | 3,285,293 | 3,285,293 | 0 | $54.01M | $20.11M | 5.64% | -$33.90M |
| Newamsterdam Pharma Co Nv ORDINARY SHARES | 770,000 | 770,000 | 0 | $19.79M | $15.76M | 4.42% | -$4.03M |
| Krystal Biotech, Inc.(KRYS) | 76,772 | 65,000 | -11,772 | $12.03M | $11.72M | 3.29% | -$307.6K |
| Revolution Medicines, Inc.(RVMD) | 226,000 | 226,000 | 0 | $9.89M | $7.99M | 2.24% | -$1.89M |
| Merus Nv | 189,098 | 189,098 | 0 | $7.95M | $7.96M | 2.23% | +$7.6K |
| BeyondSpring Inc.SHS(BYSI) | 4,882,651 | 4,882,651 | 0 | $7.96M | $6.97M | 1.96% | -$987.1K |
| Moonlake Immunotherapeutics | 171,600 | 171,600 | 0 | $9.29M | $6.70M | 1.88% | -$2.59M |
| Lyell Immunopharma, Inc.(LYEL) | 11,909,341 | 11,909,341 | 0 | $7.62M | $6.41M | 1.80% | -$1.21M |
| Arcus Biosciences, Inc.(RCUS) | 808,789 | 808,789 | 0 | $12.04M | $6.35M | 1.78% | -$5.69M |
| Aclaris Therapeutics, Inc.(ACRS) | 2,266,667 | 4,041,736 | +1,775,069 | $5.62M | $6.18M | 1.73% | +$562.5K |
| Crinetics Pharmaceuticals In | 167,958 | 177,958 | +10,000 | $8.59M | $5.97M | 1.67% | -$2.62M |
| Cytokinetics, Incorporated(CYTK) | 100,000 | 100,000 | 0 | $4.70M | $4.02M | 1.13% | -$685.0K |
| Legend Biotech CorporationADR(LEGN) | 153,558 | 100,000 | -53,558 | $5.00M | $3.39M | 0.95% | -$1.60M |
| Arcellx Inc COMMON STOCK | 84,377 | 50,000 | -34,377 | $6.47M | $3.28M | 0.92% | -$3.19M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 2,338,095 | 2,019,762 | -318,333 | $7.08M | $3.21M | 0.90% | -$3.87M |
| Aura Biosciences, Inc.(AURA) | 515,555 | 515,555 | 0 | $4.24M | $3.02M | 0.85% | -$1.22M |
| BioNTech SE(BNTX) | 40,000 | 20,000 | -20,000 | $4.56M | $1.82M | 0.51% | -$2.74M |
| Equillium, Inc.(EQ) | 4,447,308 | 4,447,308 | 0 | $3.33M | $1.74M | 0.49% | -$1.58M |
| 4d Molecular Therapeutics In | 400,000 | 335,515 | -64,485 | $2.23M | $1.08M | 0.30% | -$1.14M |
| Illumina, Inc.(ILMN) | 94,767 | 11,749 | -83,018 | $12.66M | $932.2K | 0.26% | -$11.73M |
| Pyxis Oncology, Inc.(PYXS) | 326,810 | 326,810 | 0 | $509.8K | $320.2K | 0.09% | -$189.6K |
| GRAIL, Inc.(GRAL) | 9,684 | 9,684 | 0 | $172.9K | $247.3K | 0.07% | +$74.5K |
| Vera Therapeutics, Inc.(VERA) | 49,767 | 4,495 | -45,272 | $2.10M | $108.0K | 0.03% | -$2.00M |
| Nuvation Bio Inc.WARRANTS(NUVB) | 646,057 | 646,057 | 0 | $148.6K | $44.0K | 0.01% | -$104.6K |
| AtriCure, Inc.(ATRC) | 26,797 | 0 | -26,797 | $818.9K | $0 | — | -$818.9K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 694,254 | 0 | -694,254 | $5.64M | $0 | — | -$5.64M |